Ethics, risks learned firsthand from Somanta executive

Mr. Terrance “Terry” Bruggeman discusses strategy, leadership, and the potential risks incurred with the merger of two pharmaceutical companies, as well as the ethics of bringing medical treatments to the market.  Please click on the following link to read the article in entirety: http://www.sddt.com/news/article.cfm?SourceCode=20070927czg